Faiqa Farrukh

Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia

Naseema Gangat, Isla McKerrow Johnson, Kristen McCullough et al. · Haematologica · 2022 · 49 citations · Full text

Medicine, Hematology, Oncology +8

A globally applicable “triple <scp>A</scp>” risk model for essential thrombocythemia based on <scp>A</scp>ge, <scp>A</scp>bsolute neutrophil count, and <scp>A</scp>bsolute lymphocyte count

Ayalew Tefferi, Giuseppe Gaetano Loscocco, Faiqa Farrukh et al. · American Journal of Hematology · 2023 · 38 citations · Full text

Medicine, Hematology, Immunology +10

Cerebral venous thrombosis and myeloproliferative neoplasms: A three‐center study of 74 consecutive cases

Naseema Gangat, Paola Guglielmelli, Faiqa Farrukh et al. · American Journal of Hematology · 2021 · 37 citations · Full text

Medicine, Hematology, Internal Medicine +8

Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents

Isla McKerrow Johnson, Evandro D. Bezerra, Faiqa Farrukh et al. · Blood Advances · 2022 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases

Ayalew Tefferi, Jaya Kittur, Faiqa Farrukh et al. · British Journal of Haematology · 2021 · 23 citations · Full text

Life Sciences, Hematology, Oncology +13